These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 15829414

  • 1. Oligodeoxynucleotides containing synthetic immunostimulatory motifs augment potent Th1 immune responses to HBsAg in mice.
    Li Y, Kandimalla ER, Yu D, Agrawal S.
    Int Immunopharmacol; 2005 Jun; 5(6):981-91. PubMed ID: 15829414
    [Abstract] [Full Text] [Related]

  • 2. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs.
    Wang D, Li Y, Yu D, Song SS, Kandimalla ER, Agrawal S.
    Int J Oncol; 2004 Apr; 24(4):901-8. PubMed ID: 15010828
    [Abstract] [Full Text] [Related]

  • 3. Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity.
    Wang D, Kandimalla ER, Yu D, Tang JX, Agrawal S.
    Vaccine; 2005 Apr 08; 23(20):2614-22. PubMed ID: 15780444
    [Abstract] [Full Text] [Related]

  • 4. Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice.
    Zhu FG, Kandimalla ER, Yu D, Tang JX, Agrawal S.
    Int Immunopharmacol; 2004 Jul 08; 4(7):851-62. PubMed ID: 15182725
    [Abstract] [Full Text] [Related]

  • 5. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER, Bhagat L, Li Y, Yu D, Wang D, Cong YP, Song SS, Tang JX, Sullivan T, Agrawal S.
    Proc Natl Acad Sci U S A; 2005 May 10; 102(19):6925-30. PubMed ID: 15860583
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES, Park SA, Kim SH, Cho YJ, Ahn BY, Ahn BC, Lee NG.
    FEMS Immunol Med Microbiol; 2007 Dec 10; 51(3):496-504. PubMed ID: 17877731
    [Abstract] [Full Text] [Related]

  • 7. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR, Zhu F, Li Y, Bhagat L, Cong Y, Kandimalla ER, Agrawal S.
    Nucleic Acids Res; 2006 Dec 10; 34(11):3231-8. PubMed ID: 16798912
    [Abstract] [Full Text] [Related]

  • 8. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G, Cheng Y, Wang Z, Hu Y, Zhang X, Wu M, Chen Z, Shi B, Sun S, Shen Y, Chen EJ, Yao X, Wen Y, Yuan Z.
    Vaccine; 2009 Dec 10; 28(1):187-94. PubMed ID: 19789093
    [Abstract] [Full Text] [Related]

  • 9. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
    Khajuria A, Gupta A, Malik F, Singh S, Singh J, Gupta BD, Suri KA, Suden P, Srinivas VK, Ella K, Qazi GN.
    Vaccine; 2007 Jun 06; 25(23):4586-94. PubMed ID: 17498851
    [Abstract] [Full Text] [Related]

  • 10. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G, Benjamin P, Soita H, Babiuk LA.
    Vaccine; 2008 May 23; 26(22):2680-8. PubMed ID: 18430493
    [Abstract] [Full Text] [Related]

  • 11. Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.
    Im Hof M, Williamson L, Summerfield A, Balmer V, Dutoit V, Kandimalla ER, Yu D, Zurbriggen A, Doherr MG, Peel J, Roosje PJ.
    Vet Immunol Immunopathol; 2008 Jul 15; 124(1-2):120-31. PubMed ID: 18452997
    [Abstract] [Full Text] [Related]

  • 12. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.
    McCluskie MJ, Davis HL.
    J Immunol; 1998 Nov 01; 161(9):4463-6. PubMed ID: 9794366
    [Abstract] [Full Text] [Related]

  • 13. Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma.
    Agrawal DK, Edwan J, Kandimalla ER, Yu D, Bhagat L, Wang D, Agrawal S.
    Int Immunopharmacol; 2004 Jan 01; 4(1):127-38. PubMed ID: 14975367
    [Abstract] [Full Text] [Related]

  • 14. Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice.
    Zhu FG, Kandimalla ER, Yu D, Agrawal S.
    J Allergy Clin Immunol; 2007 Sep 01; 120(3):631-7. PubMed ID: 17582479
    [Abstract] [Full Text] [Related]

  • 15. Platycodin D2 improves specific cellular and humoral responses to hepatitis B surface antigen in mice.
    Xie Y, He SW, Sun HX, Li D.
    Chem Biodivers; 2010 Jan 01; 7(1):178-85. PubMed ID: 20087984
    [Abstract] [Full Text] [Related]

  • 16. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
    Davis HL, Weeratna R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM.
    J Immunol; 1998 Jan 15; 160(2):870-6. PubMed ID: 9551923
    [Abstract] [Full Text] [Related]

  • 17. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
    Weeratna RD, Brazolot Millan CL, McCluskie MJ, Davis HL.
    FEMS Immunol Med Microbiol; 2001 Dec 15; 32(1):65-71. PubMed ID: 11750224
    [Abstract] [Full Text] [Related]

  • 18. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
    Yu D, Putta MR, Bhagat L, Li Y, Zhu F, Wang D, Tang JX, Kandimalla ER, Agrawal S.
    J Med Chem; 2007 Dec 13; 50(25):6411-8. PubMed ID: 17988082
    [Abstract] [Full Text] [Related]

  • 19. Specific immune response to HBsAg is enhanced by beta-glucan oligosaccharide containing an alpha-(1-->3)-linked bond and biased towards M2/Th2.
    Dong SF, Chen JM, Zhang W, Sun SH, Wang J, Gu JX, Boraschi D, Qu D.
    Int Immunopharmacol; 2007 Jun 13; 7(6):725-33. PubMed ID: 17466906
    [Abstract] [Full Text] [Related]

  • 20. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.
    Tudor D, Dubuquoy C, Gaboriau V, Lefèvre F, Charley B, Riffault S.
    Vaccine; 2005 Jan 26; 23(10):1258-64. PubMed ID: 15652668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.